New workshop at BEVA Congress sheds light on vaccination
3 August 2007
Vaccination is not only critical in preventing disease outbreaks, but it also forms an integral part of business for equine vet practices, creating opportunities to communicate with both current and potential clients.
With this in mind, equine health company, Intervet UK Ltd, manufacturer of the leading ‘flu and ‘flu/tetanus vaccines Equilis® Prequenza and Equilis® Prequenza Te, has joined forces with BEVA to host an ‘infectious diseases and vaccination’ workshop at this year’s BEVA Congress (12-15 September) in Edinburgh.
With the aim of providing delegates with practical information which can be used in day-to-day practice, the informal and interactive sessions will be chaired by Dr Doug Antczak from Cornell University who will also be keynote speaker at the Plenary Lecture.
Featuring internationally-recognised experts including Julia Kydd and Duncan Hannant from Nottingham Vet School, Paul Lunn from Colorado State University and Alasdair King from Intervet, the workshop will consist of a range of interesting topics. These include: practical immunology and protective immunity; investigating outbreaks of infectious disease – what samples, which tests and how to interpret results; immune responses generated by different types of vaccines; future strategies and technologies for vaccination and developing ideas into products – commercial considerations in making new vaccines.
Alasdair King, veterinary manager at Intervet comments: “We’re delighted to support the infectious diseases and vaccination workshop at BEVA Congress which will provide delegates with a wide range of practical information and a better understanding of vaccine technology.”
For further information, please contact BEVA on 01638 723555.
Company
